SMAD4 and colon carcinoma: It has been reported that NAG-1-induced growth inhibition is abolished in TGF-β receptor type I mutant R1B/L17 cells, TGF-β receptor type II mutant RKO colon carcinoma cells, and Smad4 null MDA-MB468 breast cancer cells [33].